Lattice Biologics Ltd. (LBLTF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025
Lattice Biologics Revenue
Lattice Biologics had revenue of $1.56M in the twelve months ending June 30, 2021, down -28.89% year-over-year. In the fiscal year ending September 30, 2020, Lattice Biologics had annual revenue of $2.46M with 12.60% growth.
Revenue (ttm)
1.56M
Revenue Growth
-28.89%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2020 | 2.46M | 275.71K | 12.60% |
| Sep 30, 2019 | 2.19M | 1.03M | 89.49% |
| Sep 30, 2018 | 1.16M | -1.58M | -57.84% |
| Sep 30, 2017 | 2.74M | -1.04M | -27.49% |
| Sep 30, 2016 | 3.78M | -410.28K | -9.80% |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ViewRay Systems | 105.86M |
| Micron Solutions | 18.05M |
| Lombard Medical | 12.17M |
| Avitar | 2.66M |
| Wellness Center USA | 391.24K |
| Enchanted World | 303.00K |
| Brain Scientific | 214.56K |
| Holdco Nuvo Group D.G | 176.00K |
Lattice Biologics News
- 5 years ago - Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading - Business Wire
- 5 years ago - Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies - Business Wire
- 5 years ago - Lattice Biologics Ltd. Announces Resignation of Director - Business Wire
- 5 years ago - Lattice Biologics Ltd. Reports First Quarter 2021 Highlights - Business Wire